Hims & Hers Health, Inc. · 2025 Q2
ReportedAug 5, 2025
Period endedJun 30, 2025
Rule of 40+61
Reported this quarter
Revenue
$545M
QoQ -7.0%
YoY +72.6%
EPS
$0.17
QoQ -15.0%
YoY +183.3%
Free Cash Flow
-$65M
QoQ —
YoY —
Gross Margin
76.4%
QoQ +2.9 pp
YoY -4.9 pp
FCF Margin
-12.0%
QoQ -21.1 pp
YoY -27.9 pp
P/E Ratio
35.0
QoQ -7.9%
YoY —
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 1773751.
HTML
8-K results announcement
Filed Aug 4, 2025
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
269 KB
HTM
Exhibit EX-99.2
Exhibit 99.2 to the 8-K
62 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-Q quarterly report
Period ended Jun 30, 2025, filed Aug 4, 2025
ZIP
XBRL data bundle
Structured financial statements from the 10-Q
JSON
Company facts (XBRL)
Every figure HIMS has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for 2025 Q2, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings